| Literature DB >> 25249460 |
Emmanuelle Havis1, Marie-Ange Bonnin1, Isabel Olivera-Martinez2, Nicolas Nazaret3, Mathilde Ruggiu2, Jennifer Weibel4, Charles Durand2, Marie-Justine Guerquin2, Christelle Bonod-Bidaud5, Florence Ruggiero5, Ronen Schweitzer4, Delphine Duprez6.
Abstract
The molecular signals driving tendon development are not fully identified. We have undertaken a transcriptome analysis of mouse limb tendon cells that were isolated at different stages of development based on scleraxis (Scx) expression. Microarray comparisons allowed us to establish a list of genes regulated in tendon cells during mouse limb development. Bioinformatics analysis of the tendon transcriptome showed that the two most strongly modified signalling pathways were TGF-β and MAPK. TGF-β/SMAD2/3 gain- and loss-of-function experiments in mouse limb explants and mesenchymal stem cells showed that TGF-β signalling was sufficient and required via SMAD2/3 to drive mouse mesodermal stem cells towards the tendon lineage ex vivo and in vitro. TGF-β was also sufficient for tendon gene expression in late limb explants during tendon differentiation. FGF does not have a tenogenic effect and the inhibition of the ERK MAPK signalling pathway was sufficient to activate Scx in mouse limb mesodermal progenitors and mesenchymal stem cells.Entities:
Keywords: ERK; Limb; Mouse; SMAD2/3; Scleraxis; TGF-β; Tendon; Transcriptome
Mesh:
Substances:
Year: 2014 PMID: 25249460 DOI: 10.1242/dev.108654
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868